Depression and Anxiety Management in Cirrhosis: Clinical Prevalence and Treatment Approaches

Depression and anxiety are significantly more common in cirrhosis patients than the general population, with prevalence increasing substantially over the past decade, and both conditions negatively impact quality of life and treatment outcomes. Management involves screening, pharmacological treatment with dose-adjusted antidepressants, psychotherapy, and multidisciplinary care approaches tailored to the patient's hepatic function.